c.delgado
TL2 · Genoa
Contributes reviews on supplier material. Based in Genoa.
Joined 4 October 2024 · last posted 3d
76 posts, newest first. Showing up to 150.
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #26 · Compounds › Oral incretins · 25 Jul 2026 · 26 likes Offering a way to settle PIONEER 6 cardiovascular safety rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the…
-
Common supplements people ask about, assessed one at a time Replied, post #92 · Practice › Interactions · 24 Jul 2026 · 3 likes I have no financial interest in anything named in this thread and I want to say so before I comment on common supplements, because it is the sort of subject where it…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #24 · Analytics › Mass spectrometry · 24 Jul 2026 · 8 likes Deamidation adds approximately one dalton and produces a species that frequently elutes very close to the parent. It is the hardest common impurity to see…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #97 · Evidence › Journal club · 21 Jul 2026 · 12 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. I would…
-
Seven-day rolling means and why weekly readings mislead Replied, post #74 · Outcomes › Progress reports · 21 Jul 2026 · 32 likes Worth stating the null on seven-day rolling before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #61 · Analytics › Home & field testing · 7 Jul 2026 · 10 likes The confident answers on consumer-accessible tests and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #27 · Compounds › Semaglutide · 4 Jul 2026 · 0 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
-
Reading a syringe in poor light, and how to avoid needing to — what changed since Replied, post #8 · Devices › Syringes & needles · 1 Jul 2026 · 7 likes On post #6 — agreed on the reasoning, with one qualification. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL…
-
Prescription requirements and telehealth models — a second dataset Replied, post #80 · Sourcing › Regulatory · 26 Jun 2026 · 0 likes Scheduling and prescription status are separate questions and the answer to one does not imply the other.
-
Publication patterns in the BPC-157 literature, examined Replied, post #9 · Compounds › Repair & healing peptides · 7 Jun 2026 · 6 likes The reason publication patterns is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #91 · Sourcing › Logistics · 4 Jun 2026 · 3 likes The arithmetic in post #90 is right; the assumption feeding it is the part to check. One more thing on Regional warehouse stock versus direct that took me far too long…
-
The best-written scientific paper you have read Replied, post #69 · Lounge › Off topic · 28 May 2026 · 0 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #50 · Evidence › Journal club · 27 May 2026 · 0 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. I would want a…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one… Replied, post #7 · Compounds › Retatrutide · 26 May 2026 · 0 likes On identity confirmation more generally: for a compound with no widely available reference material, orthogonal confirmation matters more than usual. A mass result and…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #69 · Clinical › Bloodwork · 16 May 2026 · 14 likes On Thyroid function tests during substantial: the maintained page in the documentation commons covers the general case with citations and a review date, which is more…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #29 · Analytics › Home & field testing · 16 May 2026 · 9 likes Answering the question post #27 raises rather than the one it answers. Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #22 · Compounds › Repair & healing peptides · 7 May 2026 · 1 like Right, and stated more narrowly than I would have dared to state it.
-
Forced degradation studies: designing one that is informative Replied, post #49 · Analytics › Method validation · 4 May 2026 · 0 likes That is clearer than the version I had in my head. Thank you.
-
Why the timeline is on the right and not the left — what changed since Replied, post #25 · Meta › Site feedback · 24 Apr 2026 · 0 likes Second this, and I would have said it less carefully.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #3 · Evidence › Journal club · 14 Apr 2026 · 18 likes Thank you for taking the time. That was more work than a reply usually is.
-
Prescription portability between countries Replied, post #6 · Access › International · 11 Apr 2026 · 20 likes The confident answers on prescription portability between countries and the well-sourced answers are not the same answers, which is the most useful thing I have learned…
-
Splitting an overlong document into two Replied, post #11 · Documentation › Wiki requests · 3 Apr 2026 · 0 likes Adding a null result on splitting an overlong document. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Mass error in ppm: the arithmetic and the caveat Replied, post #8 · Analytics › Mass spectrometry · 11 Feb 2026 · 14 likes This follows post #5 rather than contradicting it. Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to…
-
[2026 update] A rising related-substance total over six months: degradation or method… Started this topic · Analytics › Impurities & related substances · 7 Feb 2026 · 11 likes The question in the title: A rising related-substance total over six months: degradation or method drift? I will give what I have already checked below so nobody…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #6 · Compounds › Semaglutide · 12 Jan 2026 · 3 likes Adding the measurement that post #4 says would settle it. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #39 · Sourcing › Red flags · 5 Jan 2026 · 0 likes A supplier changing batch nomenclature is not a warning sign, and it does make historical comparison harder until a mapping exists.
-
Reading an interaction checker output critically Replied, post #79 · Practice › Interactions · 30 Dec 2025 · 31 likes Good question, well framed, and I would like to see it answered properly.
-
Second pass at: Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #7 · Compounds › Cagrilintide & amylin analogues · 29 Dec 2025 · 20 likes Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
-
Guidelines revision: what changed and why — one year on Replied, post #42 · Meta › Announcements · 3 Dec 2025 · 16 likes Source for the Guidelines revision figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger…
-
Reading SURMOUNT-1 without the press release Replied, post #80 · Compounds › Tirzepatide · 27 Nov 2025 · 1 like Adding a small correction to the reading SURMOUNT-1 without the press summary above rather than a disagreement with it. The substance holds; one of the figures is out…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #79 · Practice › Reconstitution · 26 Nov 2025 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #45 · Sourcing › Regulatory · 23 Nov 2025 · 17 likes That is the distinction I keep failing to hold on to. Written down now.
-
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #7 · Practice › Side effects · 21 Nov 2025 · 7 likes The arithmetic in post #5 is right; the assumption feeding it is the part to check. Injection-site reactions are usually local, brief and unremarkable. A reaction…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #14 · Compounds › Retatrutide · 5 Nov 2025 · 0 likes Understood, and I withdraw the assumption I opened with.
-
When to stop reading forums, including this one Replied, post #39 · Wellbeing › Mental health · 21 Oct 2025 · 3 likes Post #36 answers the question as asked. The question underneath it is different. Support and community: some people process weight change through community (online or…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #24 · Start Here › How to Ask · 18 Oct 2025 · 0 likes The arithmetic in post #23 is right; the assumption feeding it is the part to check. Disagreeing with an answer you got: cite what you disagree with, say what…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #2 · Start Here › How to Ask · 15 Oct 2025 · 12 likes Narrowing the opening post, because the general version has more than one answer. The specific question in the title is more useful than you might think. A title like…
-
Payment method and the leverage it gives you, ranked Replied, post #70 · Sourcing › Payments · 24 Sep 2025 · 10 likes Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are taking a risk. Reputation and history of other buyers matter. A…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #13 · Analytics › Home & field testing · 17 Sep 2025 · 11 likes I read post #11 twice before replying, because I had assumed the opposite. Where home testing is genuinely valuable is as a screen before spending on independent…
-
Documenting an adverse event properly Replied, post #2 · Safety › Adverse events · 10 Sep 2025 · 1 like Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory agency in your country can help with signal detection across the…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #53 · Data & Tools › Datasets · 8 Sep 2025 · 4 likes Post #52 is the version of this I will quote in future. One addition. The bit of Aggregated purity results across four that nobody enjoys is that the answer changes…
-
Confounding by indication, explained with a concrete example Replied, post #5 · Evidence › Study critique · 30 Aug 2025 · 32 likes Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #37 · Evidence › Journal club · 22 Aug 2025 · 2 likes Second this, and I would have said it less carefully.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #29 · Compounds › Secretagogues & GH axis · 2 Aug 2025 · 0 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #73 · Compounds › Cagrilintide & amylin analogues · 24 Jul 2025 · 2 likes The phase 3 combination programme is where the clinically interesting numbers will come from. Phase 2 established that the combination does something; the size of it in…
-
Tracking that stops updating and then resumes Replied, post #10 · Sourcing › Logistics · 15 Jul 2025 · 4 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #63 · Evidence › Journal club · 3 Jul 2025 · 15 likes That is a fair summary of where the discussion has got to.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #30 · Data & Tools › Calculators · 20 Jun 2025 · 12 likes The arithmetic in post #27 is right; the assumption feeding it is the part to check. Marking my uncertainty on titration planner refuses explicitly. I am confident…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #27 · Compounds › Cagrilintide & amylin analogues · 12 Jun 2025 · 0 likes Everything in post #23 holds. The case it does not cover is the one I have. I would keep Reading a combination trial and the decision it usually gets used for separate…
-
Half-life, steady state, and accumulation worked through Replied, post #38 · Pharmacology › Pharmacokinetics · 29 May 2025 · 22 likes That is consistent with mine, for whatever one more account is worth.
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #5 · Practice › Reconstitution · 28 May 2025 · 28 likes Building on post #2 rather than restating it. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in…
-
Follow-up: Documentation that appears only after payment Replied, post #73 · Sourcing › Red flags · 13 May 2025 · 24 likes Post #71 and I disagree about the size of the effect, not about the direction. The useful distinction on Documentation is between what was measured and what was…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #98 · Access › Pricing · 13 May 2025 · 2 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Carryover and the ghost peak from last week's standard Replied, post #87 · Analytics › HPLC & UHPLC · 12 Apr 2025 · 0 likes Trifluoroacetic acid at 0.1 per cent is the near-universal ion-pairing additive for this work, and it also raises the baseline at 214 nanometres. That is why the same…
-
Carryover and the ghost peak from last week's standard Replied, post #62 · Analytics › HPLC & UHPLC · 9 Apr 2025 · 0 likes Carryover has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Follow-up: What other technical communities get right that we do not Replied, post #53 · Lounge › Off topic · 30 Mar 2025 · 5 likes Lounge-level thought to close on: the measure of this place is that being wrong in public here is cheap. That is a design decision and it took work.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #50 · Practice › Reconstitution · 29 Mar 2025 · 9 likes Where I have landed on reconstituting a multi-strength kit, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #45 · Compounds › Semaglutide · 19 Mar 2025 · 26 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Maintainer handover: how it works Replied, post #35 · Meta › Wiki maintenance · 15 Mar 2025 · 22 likes For anyone finding this later: the short answer on maintainer handover is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
Checking someone else's arithmetic: a worked example thread Replied, post #25 · Practice › Reconstitution · 26 Feb 2025 · 5 likes Where I part company with post #21, and it is a narrow parting. Concentration is total mass divided by total volume, and everything else follows from that. Ten…
-
When to suspect the method rather than the sample Replied, post #86 · Analytics › Method validation · 22 Feb 2025 · 1 like Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
A page that has drifted out of date and needs a maintainer Replied, post #65 · Documentation › Wiki requests · 17 Feb 2025 · 2 likes Suggesting content for a page: if you know a maintained page is missing something important, post a suggestion with specific content you think should be added. The…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #5 · Compounds › Tirzepatide · 19 Jan 2025 · 1 like Whatever the answer on GIP component of tirzepatide turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite…
-
The topic list is dense — is that deliberate? Replied, post #84 · Meta › Site feedback · 17 Jan 2025 · 0 likes What I would want before treating topic list as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #92 · Access › Insurance & coverage · 28 Dec 2024 · 10 likes Worth stating the null on Step therapy requirements before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get…
-
Coming back to: When to suspect the method rather than the sample Replied, post #129 · Analytics › Method validation · 25 Dec 2024 · 0 likes Taking post #126 at face value and following it one step further. Accuracy: the method measures what you intend to measure. For purity methods, this is tested by…
-
EMA product information as a primary source — does this still hold? Replied, post #44 · Regional › European Union · 16 Nov 2024 · 7 likes Taking post #41 at face value and following it one step further. What I would check first on EMA product information is whether the thing being measured moved or…
-
Time to steady state after a dose increase Replied, post #159 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 0 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Time to steady state after a dose increase Replied, post #15 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 11 likes Body weight affects volume of distribution and therefore exposure at a fixed dose. Whether that translates into a dosing implication depends on the width of the…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #9 · Access › Insurance & coverage · 30 Oct 2024 · 0 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
Here for the analytics and not much else — one year on Replied, post #3 · Lounge › Introductions · 28 Oct 2024 · 14 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #7 · Wellbeing › Mental health · 27 Sep 2024 · 1 like I have three months of notes on Food noise and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #37 · Analytics › Method validation · 21 Sep 2024 · 29 likes The arithmetic in post #36 is right; the assumption feeding it is the part to check. Transfer between laboratories: a method can be transferred from one lab to another,…
-
Meeting a protein target on a suppressed appetite — one year on Replied, post #19 · Nutrition & Training › Protein & intake · 20 Sep 2024 · 5 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #22 · Clinical › Special populations · 8 Sep 2024 · 11 likes Extrapolating a point estimate to somebody well outside the enrolled range should be described as an extrapolation every time it is done.
-
Blind submission and why it changes minds Replied, post #27 · Sourcing › Independent verification · 2 Aug 2024 · 1 like Post #23 describes the usual case. This is about the unusual one. A record with four results over sixteen months is a thin record rather than a bad one, and the honest…